APA

Visani G., Tosi P., Zinzani P. L., Manfroi S., Ottaviani E., Cenacchi A., Carrara P., Clavio M., Gobbi M. & Tura S. (19960712). FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects. : European journal of haematology.

Chicago

Visani G, Tosi P, Zinzani P L, Manfroi S, Ottaviani E, Cenacchi A, Carrara P, Clavio M, Gobbi M and Tura S. 19960712. FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects. : European journal of haematology.

Harvard

Visani G., Tosi P., Zinzani P. L., Manfroi S., Ottaviani E., Cenacchi A., Carrara P., Clavio M., Gobbi M. and Tura S. (19960712). FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects. : European journal of haematology.

MLA

Visani G, Tosi P, Zinzani P L, Manfroi S, Ottaviani E, Cenacchi A, Carrara P, Clavio M, Gobbi M and Tura S. FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects. : European journal of haematology. 19960712.